Literature DB >> 31913428

Errors in Table 2 and Figure 2.

.   

Abstract

Year:  2020        PMID： 31913428      PMCID： PMC6990760          DOI： 10.1001/jamadermatol.2019.4551

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  1 in total

1.  Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis: A Phase 2 Randomized Clinical Trial.

Authors:  Melinda J Gooderham; Seth B Forman; Robert Bissonnette; Jean S Beebe; Weidong Zhang; Chris Banfield; Linda Zhu; Jocelyne Papacharalambous; Michael S Vincent; Elena Peeva
Journal:  JAMA Dermatol       Date:  2019-12-01       Impact factor: 10.282
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.